XRP is approaching a decisive technical crossroads as buyers defend a historically active support zone, placing the asset at a critical moment that could shape XRP is approaching a decisive technical crossroads as buyers defend a historically active support zone, placing the asset at a critical moment that could shape

XRP Price Prediction: XRP Trades in $1.39–$1.46 Range as Buyers Defend Key Support

2026/02/11 05:45
Okuma süresi: 5 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen [email protected] üzerinden bizimle iletişime geçin.

The XRP price today is fluctuating around the $1.40–$1.41 range after rebounding from earlier lows. This level has repeatedly acted as a structural pivot on recent charts, drawing attention from both short-term traders and longer-term investors who are closely monitoring whether the current XRP price can establish a stable base for continuation rather than another retracement.

Recent price behavior shows a clear demand response. After sliding toward $1.12, the price of XRP attracted consistent buying interest and staged a recovery back above $1.30 before compressing near $1.40. Rather than a sharp spike, the rebound developed through multiple higher lows, a pattern typically associated with accumulation rather than short covering.

From a market structure perspective, holding above $1.40 keeps the short-term bias constructive while broader conditions remain mixed.

Price Structure Stabilizes Above Key Support

On the weekly timeframe, XRP has established a demand zone between $1.11 and $1.36. This range is not arbitrary. It aligns with prior high-volume consolidation from earlier trading periods where several weekly closes repeatedly attracted buyers. Historically, similar zones have acted as bases before relief rallies.

After rebounding from $1.12 demand, XRP is consolidating near the key $1.40 level, where sustained support could confirm bullish continuation toward $1.58, $1.82, and $2.15 despite the broader downtrend. Source: ArmanShabanTrading on TradingView

Resistance levels are derived from prior structural highs rather than speculative projections:

  • $1.58—previous swing high and local supply

  • $1.82—upper boundary of the last weekly consolidation range

  • $2.15—broader range extension and historical liquidity area

Because these levels coincide with earlier rejection zones, they are considered logical checkpoints where selling pressure could reappear.

Momentum indicators have also moderated. Volatility has narrowed, and candles have shortened, signaling compression. In technical analysis, tightening ranges often precede directional moves, though confirmation requires sustained closes beyond resistance rather than brief intraday spikes.

Short-Term XRP Chart Signals Compression

On the 4-hour XRP chart, price remains in a corrective phase within a defined corridor between approximately $1.39 and $1.46.

XRP, currently ranked #4 by market cap, is in a short-term corrective phase within a $1.3926–$1.4565 compression range, with key breakout levels at $1.2113 (bearish) and $1.5175 (bullish) guiding potential trades. Source: tradecitypro on TradingView

This range has formed through multiple tests on both sides, suggesting a balance between buyers and sellers. Breaks from such compression zones typically provide clearer directional signals.

Key levels being monitored:

  • Above $1.4565: early bullish confirmation

  • Above $1.5175: stronger structural breakout toward $1.65–$1.77

  • Below $1.3926: renewed downside risk toward $1.21

These levels correspond to recent swing highs and lows, meaning they represent areas where liquidity previously changed hands.

For short-term participants, sustained closes matter more than quick wicks. A daily or 4-hour close beyond resistance would carry more analytical weight than temporary moves.

Macro and Regulatory Context: Ripple XRP and Institutional Clarity

Beyond chart structure, Ripple XRP continues to trade within a distinct regulatory framework compared with many large-cap digital assets.

Following a confirmed major low and strong recovery, XRP shows signs of a short-term relief rally, supporting a leveraged long setup from $1.35 to $1.48 with upside targets extending to $3.22 while maintaining risk control below $1.30. Source: MasterAnanda on TradingView

The long-running XRP SEC lawsuit has materially reduced legal uncertainty around Ripple’s operations in the United States. While not eliminating all regulatory considerations, the outcome clarified several classification questions that had previously limited institutional engagement.

Importantly, legal clarity does not automatically translate into price gains. Instead, it lowers perceived risk for funds, custodians, and payment partners evaluating the Ripple XRP price and broader adoption of the XRP Ledger.

Ongoing discussions around potential ETF products or institutional vehicles remain speculative. Analysts generally treat them as secondary factors rather than primary drivers of the XRP price forecast.

In practice, regulatory stability functions more as a structural backdrop than a short-term catalyst.

Market Position and Sentiment

Despite recent volatility, XRP remains one of the largest cryptocurrencies by XRP market cap, consistently ranking among the top assets by liquidity and trading volume. This depth often reduces extreme price gaps compared with smaller tokens and allows institutional-sized orders to execute more efficiently.

XRP was trading at around $1.413, up 0.83% in the last 24 hours at press time. Source: Brave New Coin

Sentiment remains balanced rather than euphoric. Some participants interpret the current base as early stabilization, while others point to the longer-term downtrend that began in mid-2025 as a reason for caution.

This split view explains the present consolidation: buyers are defending support, but conviction has not yet produced a decisive breakout.

Final Thoughts

The XRP price today sits at a clear inflection point. Holding above $1.40 keeps the near-term structure intact and leaves room for a move toward $1.82, based on prior range highs. Losing that level would likely shift focus back to $1.21 and the lower demand zone.

For now, XRP appears to be transitioning from sharp declines to consolidation. Such phases often precede larger moves, but confirmation, not anticipation, remains the more disciplined approach.

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Paylaş
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Paylaş
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26